摘要
Primary percutaneous coronary intervention （PCI） has been the standard of care for patients with acuteST-elevation myocardial infarction hours of symptom onset in modem and applications of robust （STEMI） within 12 era.1＇2 The advances anti-platelet and anti-coagulation medicines further improve the outcome of STEMI patients undergoing primary PCI^3 ,and
Primary percutaneous coronary intervention （PCI） has been the standard of care for patients with acuteST-elevation myocardial infarction hours of symptom onset in modem and applications of robust （STEMI） within 12 era.1＇2 The advances anti-platelet and anti-coagulation medicines further improve the outcome of STEMI patients undergoing primary PCI^3 ,and
